Synthesis and evaluation of di-heterocyclic benzazole compounds as potential antibacterial and anti-biofilm agents against Staphylococcus aureus
dc.contributor.author | Aktekin, Mine Buga | |
dc.contributor.author | Oksuz, Zehra | |
dc.contributor.author | Turkmenoglu, Burcin | |
dc.contributor.author | Istifli, Erman Salih | |
dc.contributor.author | Kuzucu, Mehmet | |
dc.contributor.author | Algul, Oztekin | |
dc.date.accessioned | 2025-03-17T12:25:37Z | |
dc.date.available | 2025-03-17T12:25:37Z | |
dc.date.issued | 2024 | |
dc.department | Tarsus Üniversitesi | |
dc.description.abstract | Cumulative escalation in antibiotic-resistant pathogens necessitates the quest for novel antimicrobial agents, as current options continue to diminish bacterial resistance. Herein, we report the synthesis of di-heterocyclic benzazole structures (12-19) and their in vitro evaluation for some biological activities. Compounds 16 and 17 demonstrated potent antibacterial activity (MIC = 7.81 mu g/mL) against Staphylococcus aureus, along with significant anti-biofilm activity. Noteworthy is the capability of Compound 17 to inhibit biofilm formation by at least 50% at sub-MIC (3.90 mu g/mL) concentration. Furthermore, both compounds exhibited the potential to inhibit preformed biofilm by at least 50% at the MIC concentration (7.81 mu g/mL). Additionally, Compounds 16 and 17 were examined for cytotoxic effects in HFF-1 cells, using the MTT method, and screened for binding interactions within the active site of S. aureus DNA gyrase using in silico molecular docking technique, employing AutoDock 4.2.6 and Schr & ouml;dinger Glidse programs. Overall, our findings highlight Compounds 16 and 17 as promising scaffolds warranting further optimization for the development of effective antibacterial and anti-biofilm agents. | |
dc.description.sponsorship | Mersin University [2021-1-TP3-4120] | |
dc.description.sponsorship | Mersin University, Grant/Award Number: 2021-1-TP3-4120 | |
dc.identifier.doi | 10.1111/cbdd.14601 | |
dc.identifier.issn | 1747-0277 | |
dc.identifier.issn | 1747-0285 | |
dc.identifier.issue | 2 | |
dc.identifier.pmid | 39085984 | |
dc.identifier.scopus | 2-s2.0-85200154626 | |
dc.identifier.scopusquality | Q2 | |
dc.identifier.uri | https://doi.org/10.1111/cbdd.14601 | |
dc.identifier.uri | https://hdl.handle.net/20.500.13099/1783 | |
dc.identifier.volume | 104 | |
dc.identifier.wos | WOS:001281451200001 | |
dc.identifier.wosquality | Q2 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | |
dc.publisher | Wiley | |
dc.relation.ispartof | Chemical Biology & Drug Design | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.snmz | KA_WOS_20250316 | |
dc.subject | anti-biofilm activity | |
dc.subject | antimicrobial | |
dc.subject | cytotoxicity | |
dc.subject | di-heterocyclic benzazole | |
dc.subject | molecular docking | |
dc.subject | synthesis | |
dc.title | Synthesis and evaluation of di-heterocyclic benzazole compounds as potential antibacterial and anti-biofilm agents against Staphylococcus aureus | |
dc.type | Article |